[Serous-papillary cystadenocarcinoma of the ovary: problems in the CT identification of calcified intraperitoneal metastases].

Rofo

Radiologisches Zentrum, Abteilung für Röntgendiagnostik, Klinikum Nord der Stadt Nürnberg.

Published: March 1993

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1032651DOI Listing

Publication Analysis

Top Keywords

[serous-papillary cystadenocarcinoma
4
cystadenocarcinoma ovary
4
ovary problems
4
problems identification
4
identification calcified
4
calcified intraperitoneal
4
intraperitoneal metastases]
4
[serous-papillary
1
ovary
1
problems
1

Similar Publications

Article Synopsis
  • A 77-year-old woman with worsening coordination issues and anti-Yo antibodies was suspected of having paraneoplastic cerebellar degeneration (PCD).
  • After examining her for cancer, doctors found and removed a mass in the Douglas fossa, later identified as stage IIB peritoneal serous papillary carcinoma (PSPC), which is challenging to detect early.
  • The PCD was treated with intravenous immunoglobulin (IVIG), highlighting the need for early diagnosis and treatment of PSPC as a possible cause of PCD linked to anti-Yo antibodies.
View Article and Find Full Text PDF

Objective: To compare survival measures of women with Stage I high-grade endometrial cancer who underwent either hysteroscopy or a non-hysteroscopic procedure as a diagnostic procedure.

Study Design: 298 patients with stage I high grade endometrial cancer who underwent surgery between 2002 and 2014. Patients were divided into two groups: hysteroscopy and non-hysteroscopy (curettage or office endometrial biopsy).

View Article and Find Full Text PDF

Factor affecting lymph node metastasis in uterine papillary serous carcinomas: a retrospective analysis.

J Obstet Gynaecol

November 2022

Department of Gynecologic Oncology, Faculty of Medicine, Ankara City Hospital, University of Health Sciences, Ankara, Turkey.

The aim of this study was to investigate the risk factors for lymph node metastasis (LNM) in patients with uterine serous cancer (USC) who underwent systematic staging surgery. Eighty patients who were operated on for pure uterine serous papillary carcinoma between 2008 and 2020 in our clinic were retrospectively analysed. The effects of demographic information and clinicohistopathological characteristics of the included patients on LNM were examined.

View Article and Find Full Text PDF

High gene expression predicts response to chemotherapy and prognosis of high-grade serous ovarian cancer patients.

J Int Med Res

November 2022

Department of Intensive Care Unit, Hebei Medical University, Fourth Hospital, Shijiazhuang, China.

Article Synopsis
  • High-grade serous ovarian cancer (HGSOC) is a severe form of cancer linked to aberrant differentiation, with homeobox protein A9 (HoxA9) playing a key role in this process.
  • The study used quantitative PCR and immunohistochemistry to analyze mRNA and protein levels of HoxA9, finding that increased expression levels correlated with chemotherapy resistance and worse clinical outcomes.
  • The findings suggest that high HoxA9 expression serves as an independent prognostic indicator for poor survival in HGSOC patients, potentially guiding future treatment strategies.
View Article and Find Full Text PDF

Objective: Endometrial cancer prognosis is related to stage, histology, myometrial invasion, and lymphovascular space invasion. Several studies have examined the association between pretreatment thrombocytosis and patient outcomes with contrasting results regarding prognosis. Our aim was to evaluate the association of pretreatment platelet count with outcomes in endometrial cancer patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!